Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Kalydeco |
| Active Ingredient: | Ivacaftor 150mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturers: | Patheon Pharmaceuticals Inc, Ohio, United States of America Aesica Queenborough Limited, Queenborough, United Kingdom |
| Product: | Nurofen for Children 3 months – 5 years (Orange flavour) |
| Active Ingredient: | Ibuprofen 20mg/mL |
| Dosage Form: | Oral suspension |
| New Zealand Sponsor: | Reckitt Benckiser (New Zealand) Limited |
| Manufacturers: | Reckitt Benckiser Healthcare (UK) Limited, Hull, United Kingdom Reckitt Benckiser Healthcare India Private Limited, Baddi, India |
| Product: | Nurofen for Children 3 months – 5 years (Strawberry flavour) |
| Active Ingredient: | Ibuprofen 20mg/mL |
| Dosage Form: | Oral suspension |
| New Zealand Sponsor: | Reckitt Benckiser (New Zealand) Limited |
| Manufacturers: | Reckitt Benckiser Healthcare (UK) Limited, Hull, United Kingdom Reckitt Benckiser Healthcare India Private Limited, Baddi, India |
Dated this 29th day of January 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).